Specialty Pharmaceuticals Businesses for Sale in Visakhapatnam

Established in Vizag JN Pharma City, this API manufacturer operates in a prime location known for its robust infrastructure in the pharmaceuticals industry, catering to domestic and international markets. - Specializes in high-demand active pharmaceutical ingredients (APIs) across various therapeutic categories including oncology, diabetes, cardiovascular, and anti-allergic drugs, appealing to top pharmaceutical formulators both in India and abroad. - Boasts a strong international presence with export relationships across Japan, UK, France, and Bangladesh, indicating its credibility and demand in diverse markets. - Serves a substantial client base of 40 to 50, highlighting a stable and expanding market reach with an emphasis on both domestic and export clientele. - The facility has an advanced production capacity of 98 kiloliters, with the potential to scale operations to 250 kiloliters, underscoring its readiness for increased demand and large-scale API manufacturing. - Holds ISO 9000 certification, underscoring its commitment to quality management systems and ensuring compliance with internationally recognized standards. - The business is incorporated and features USFDA approval for one of its products, reinforcing its competitive position and enabling access to the lucrative US pharmaceuticals market. - The operations have been halted due to non-payment of a working capital loan, and the bank has seized the assets due to NPA.

Established in Vizag JN Pharma City, this API manufacturer operates in a prime location known for its robust infrastructure in the pharmaceuticals industry, catering to domestic and international markets. - Specializes in high-demand active pharmaceutical ingredients (APIs) across various therapeutic categories including oncology, diabetes, cardiovascular, and anti-allergic drugs, appealing to top pharmaceutical formulators both in India and abroad. - Boasts a strong international presence with export relationships across Japan, UK, France, and Bangladesh, indicating its credibility and demand in diverse markets. - Serves a substantial client base of 40 to 50, highlighting a stable and expanding market reach with an emphasis on both domestic and export clientele. - The facility has an advanced production capacity of 98 kiloliters, with the potential to scale operations to 250 kiloliters, underscoring its readiness for increased demand and large-scale API manufacturing. - Holds ISO 9000 certification, underscoring its commitment to quality management systems and ensuring compliance with internationally recognized standards. - The business is incorporated and features USFDA approval for one of its products, reinforcing its competitive position and enabling access to the lucrative US pharmaceuticals market. - The operations have been halted due to non-payment of a working capital loan, and the bank has seized the assets due to NPA.